Robert Foley
Analyst · BTIG. Please go ahead.
Sure. Eric a good question with respect to unfunded commitments, which at quarter end stood around $440 million or so. Interestingly, an increasing share of our unfunded commitments relate to our lending initiative and life sciences sector in which we've been active since 2015 2016. Those transactions typically involve, fairly substantial conversions of existing properties, we've got a theme there that we'd be happy to discuss separately, but we're generally as Matt said earlier, not doing roundup construction. So the factors that drive the pace at which dollars are infused into a life sciences transaction are decidedly well, they are the same, but the dynamics of the market are very different in life sciences than they are in office. Generally speaking, in our office portfolio, the unfunded commitment dollars relate to what we call good news money, which are TI expenditures and leasing conditions, those are typically shared between us in our borrow and proportion to our advance rate against the loan as a whole, which is typically in the 65% to 70% range. So those dollars are typically funded only when a qualifying lease that is a lease that meets our minimum leasing guidelines, and has been consented to by us is signed, the pace of those fundings during COVID has slowed, which is to be expected. And, you know, as different markets begin to rebound at different paces, we expect, we may see some additional increases in the future. But right now, it has been pretty slow. And we commented earlier on our liquidity position, which is quite strong. And we typically, when we do make a deferred funding, we typically finance a portion of that with one of our lenders, so that we'd be funding the equity component of our portion of the total draw, our lender would fund the other portion, and then our borrower would fund the last 25% to 30%. Hope that answers your question.